Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jeffrey G. Supko, Ph.D.

Concepts (512)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Jeffrey Supko's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Jeffrey Supko has written about over time.
Chromatography, High Pressure Liquid, 15 publications between 1991 and 2009, average publication date April 1999. Isoquinolines, 10 publications between 1994 and 2005, average publication date November 2000. Isoflavones, 3 publications between 1995 and 2007, average publication date October 2002. Dioxoles, 6 publications between 2001 and 2005, average publication date March 2003. Camptothecin, 12 publications between 1993 and 2012, average publication date October 2003. Infusions, Intravenous, 21 publications between 1995 and 2020, average publication date October 2004. Paclitaxel, 14 publications between 1999 and 2020, average publication date July 2006. Antineoplastic Agents, Phytogenic, 6 publications between 2001 and 2020, average publication date October 2007. Antineoplastic Agents, 47 publications between 1991 and 2023, average publication date June 2008. Maximum Tolerated Dose, 31 publications between 2001 and 2020, average publication date December 2009. Neoplasm Recurrence, Local, 17 publications between 2001 and 2017, average publication date January 2010. Benzamides, 6 publications between 1995 and 2020, average publication date July 2010. Antineoplastic Combined Chemotherapy Protocols, 40 publications between 1999 and 2023, average publication date September 2010. Quinazolines, 5 publications between 2004 and 2017, average publication date December 2010. Glioma, 17 publications between 2000 and 2020, average publication date December 2010. Brain Neoplasms, 25 publications between 2000 and 2023, average publication date March 2012. Asparaginase, 7 publications between 2009 and 2021, average publication date January 2014. Precursor Cell Lymphoblastic Leukemia-Lymphoma, 6 publications between 2010 and 2021, average publication date October 2014. Glioblastoma, 8 publications between 2008 and 2023, average publication date March 2015. Receptor, Platelet-Derived Growth Factor beta, 1 publications between 2017 and 2017, average publication date March 2017.

To see the data from this visualization as text, click here.
Supko's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (512)
Explore
_
Co-Authors (147)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.